Discover our latest news, updates and press releases

Rio de Janeiro, Brazil – November 29, 2024 – During the Belgian Economic Mission to Brazil, a historic Memorandum of Understanding (MoU) was signed between the Brazilian Oswaldo Cruz Foundation (Fiocruz) through its Institute of Technology on Immunobiologicals (Bio-Manguinhos), and the Belgian companies Quantoom Biosciences S.A. and Univercells S.A. in the presence of Her Royal […]

Brussels, Belgium and Pune, India – In a landmark collaboration announced today, Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells, a Belgian biotech innovator, targeting a dramatic increase in accessibility to personalised cancer care. This partnership aims to bring cutting edge treatment options within reach of millions globally. At […]

HAMILTON, BERMUDA – March 25, 2024 – Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, today announced that it has entered into a collaboration agreement with Univercells Group (“Univercells”) to evaluate the use of the Company’s proprietary SemaPhore platform for the delivery […]

Last Monday Univercells had the honor of hosting HE Muhammad Ali Pate, the Minister of Health and Social Welfare of the Republic of Nigeria, and Dr. Abdu Mukhtar, National Coordinator, Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC). This event took place under the patronage of Univercells’ CEO, Hugues Bultot along with the presence […]

Gosselies, Belgium – February 9, 2024 – EU Biotech Campus, a new state-of-the-art and multi-operator training center for the health & biotech sector, and Univercells, a global life sciences player, are delighted to announce a long-term training collaboration. This partnership aims to provide a dynamic learning environment for Belgian and international students and professionals while […]

DAKAR (October 9, 2023) – Today at the 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale. The move builds […]

The company continues to deliver on the commitment to bring innovative and cost-effective technologies to the global market to make biologics more accessible.  Andover, MA and Brussels (Belgium) — Univercells, a Belgian biotechnology company dedicated to ensuring that everyone has access to biologics everywhere in the world, is pleased to announce the opening of the […]

Unizima announces new academic partnerships, and enhanced cooperation between academic and private actors from Senegal, Rwanda and Belgium around a joint Master’s degree in biotechnology. To support the capacity building needed to enable autonomous vaccine production in Africa, Unizima, an affiliate of the Univercells Group, the University Cheikh Anta Diop of Dakar (Senegal), the University […]

Quantoom Biosciences S.A. (“Quantoom”), a Univercells company, is establishing a team in the United States. The company has appointed Oladimeji Fashola as Chief Technology Officer, and Business Development team of three. These crucial additions mark an exciting phase of growth for the company and underline its commitment to expanding its presence in the U.S. market. […]

Dakar (Senegal) – May 24, 2023 Her Royal Highness Princess Astrid is currently presiding over the first royal Belgian mission to Senegal from May 21 until May 25. This economic mission has been organized by the Foreign Trade Agency, the three regional Belgian agencies for the promotion of foreign trade and investment, and the Federal […]